Delivery Order SPE2DB20D2104-SPE2DB23FU34E
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $51,308.77 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 6, 2024. The contract is not designated as a set-aside award. Amerisourcebergen is the prime contractor for this delivery order, which is part of a larger $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,612.34 for Ozempic 0.25-0.5 mg/dose pens. The award was made by the Defense Logistics Agency (DLA), a defense agency. The contract has a completion date of January 8, 2024 and uses a firm fixed price pricing structure. There is no set-aside designation for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $23,254.67 firm-fixed-price delivery order has a completion date of February 22, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $3,697.45 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on May 19, 2023, with a completion date of May 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,963.13 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $5,805.26 delivery order is for the pharmaceutical product Ozempic 0.25-0.5 mg/dose pen 3 mL. The contract has an ultimate completion date of April 12, 2024 and is a firm fixed-price delivery order. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,257.96 firm fixed-price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a completion date of September 8, 2023. Amerisourcebergen is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Ozempic 0.25-0.5 mg/dose pens. The $37,548.83 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 25, 2024. The contract is a delivery order and was not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml. The $4,609.06 firm fixed-price delivery order has a completion date of December 5, 2023. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was granted to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The $15,908.85 firm fixed price delivery order is for the supply of Ozempic 0.25-0.5 mg/dose pens with a performance period through December 4, 2023. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999.00...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB23FU34EDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of Ozempic 0.25-0.5 mg/dose pens with a 3 ml capacity. The $3,483.24 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 12, 2023, with a period of performance through July 13, 2023. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen, a major pharmaceutical distributor, holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to supply a comprehensive range of pharmaceutical products and medical supplies to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 7/12/23 |